CircSOD2 induced epigenetic alteration drives hepatocellular carcinoma progression through activating JAK2/STAT3 signaling pathway
Zhongwei Zhao(Central South University), Jiansong Ji(Wenzhou Medical University), Liyun Zheng(Lishui Central Hospital), Jianfei Tu(Lishui Central Hospital), Jingjing Song(Lishui Central Hospital), Chunmiao Chen(Wenzhou Medical University), Dengke Zhang(Wenzhou Medical University), Qiaoyou Weng(Wenzhou Medical University), Xianghua Hu(Wenzhou Medical University), Yang Yang(Shijiazhuang Yiling Pharmaceutical (China)), Shiji Fang(Wenzhou Medical University), Fazong Wu(Wenzhou Medical University), Yang Gao(Lishui Central Hospital), Bufu Tang(Lishui Central Hospital)
Cited by 3
Related Papers
Comprehensive molecular characterization of mitochondrial genomes in human cancers
|Nature Genetics|2020|516
<i><scp>ZKSCAN</scp>1</i> gene and its related circular <scp>RNA</scp> (circ<i><scp>ZKSCAN</scp>1</i>) both inhibit hepatocellular carcinoma cell growth, migration, and invasion but through different signaling pathways
|Molecular Oncology|2017|314
The ferroptosis and iron-metabolism signature robustly predicts clinical diagnosis, prognosis and immune microenvironment for hepatocellular carcinoma
|Cell Communication and Signaling|2020|232
Regulatory T cells, especially ICOS+ FOXP3+ regulatory T cells, are increased in the hepatocellular carcinoma microenvironment and predict reduced survival
|Scientific Reports|2016|143
CircSOD2 induced epigenetic alteration drives hepatocellular carcinoma progression through activating JAK2/STAT3 signaling pathway
|Journal of Experimental & Clinical Cancer Research|2020|107